Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

Anticancer research - 1 Jan 2000

Miyatake Kazuyo, Gemba Kenichi, Ueoka Hiroshi, Nishii Kenji, Kiura Katsuyuki, Tabata Masahiro, Shibayama Takuo, Takigawa Nagio, Kawaraya Masashi, Tanimoto Mitsune

Abstract excerpt

BACKGROUND: The prognostic significance of mutant p53 protein, p-glycoprotein (P-gp) and glutathione S-transferase-pi (GST-pi) in patients with unresectable non-small cell lung cancer (NSCLC) has not been established. MATERIALS AND METHODS: We performed immunohistochemical staining of p53, P-gp and GST-pi using transbronchial biopsy specimens obtained from previously untreated NSCLC patients. RESULTS: Of 45...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to ATP Binding Cassette Transporter, Subfamily B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Carcinoma, Non-Small-Cell Lung

Share to Cisplatin

Share to Glutathione Transferase

Share to Multivariate Analysis

Share to Survival Rate

Source

Identifiers

PMID: 12926120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.PMID 12926120Read ↗

Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.Semantic proximity Read ↗

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.Semantic proximity Read ↗

Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.Semantic proximity Read ↗

Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.Semantic proximity Read ↗

The role of p53 in treatment responses of lung cancer.Semantic proximity Read ↗

[Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer].Semantic proximity Read ↗

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.Semantic proximity Read ↗

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.Semantic proximity Read ↗

Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.Semantic proximity Read ↗

Prognostic significance of different biomarkers in non-small cell lung cancer.Semantic proximity Read ↗

Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.